Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis
Qianwen Zhao, Meng Meng, Rahul Kumar, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 10, pp. 1915-1921
Open Access | Times Cited: 735

Showing 1-25 of 735 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Comorbidity and its Impact on Patients with COVID-19
Adekunle Sanyaolu, Chuku Okorie, Aleksandra Marinkovic, et al.
SN Comprehensive Clinical Medicine (2020) Vol. 2, Iss. 8, pp. 1069-1076
Open Access | Times Cited: 1496
COVID-19 and comorbidities: Deleterious impact on infected patients
Hasan Ejaz, Abdullah Alsrhani, Aizza Zafar, et al.
Journal of Infection and Public Health (2020) Vol. 13, Iss. 12, pp. 1833-1839
Open Access | Times Cited: 931
Smoking Is Associated With COVID-19 Progression: A Meta-analysis
Roengrudee Patanavanich, Stanton A. Glantz
Nicotine & Tobacco Research (2020) Vol. 22, Iss. 9, pp. 1653-1656
Open Access | Times Cited: 653
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
Qianwen Zhao, Meng Meng, Rahul Kumar, et al.
International Journal of Infectious Diseases (2020) Vol. 96, pp. 131-135
Open Access | Times Cited: 472
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
Alain Borczuk, Steven Salvatore, Surya V. Seshan, et al.
Modern Pathology (2020) Vol. 33, Iss. 11, pp. 2156-2168
Open Access | Times Cited: 445
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis
Rohin K. Reddy, Walton N. Charles, Alexandros Sklavounos, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 2, pp. 1045-1056
Open Access | Times Cited: 436
Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
Joan C. Smith, Erin L. Sausville, Vishruth Girish, et al.
Developmental Cell (2020) Vol. 53, Iss. 5, pp. 514-529.e3
Open Access | Times Cited: 393
Blood type and outcomes in patients with COVID-19
Christopher A. Latz, Charles DeCarlo, Laura T. Boitano, et al.
Annals of Hematology (2020) Vol. 99, Iss. 9, pp. 2113-2118
Open Access | Times Cited: 347
COVID-19 and addiction
Mahua Jana Dubey, Ritwik Ghosh, Subham Chatterjee, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 5, pp. 817-823
Open Access | Times Cited: 328
Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity
Jiaofeng Huang, Aiguo Cheng, Rahul Kumar, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 10, pp. 2152-2158
Open Access | Times Cited: 325
IL-6: Relevance for immunopathology of SARS-CoV-2
Ekaterina O. Gubernatorova, Е. А. Горшкова, Almina I. Polinova, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 13-24
Open Access | Times Cited: 312
Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature
Kalpana Thapa Bajgain, Sujan Badal, Bishnu Bahadur Bajgain, et al.
American Journal of Infection Control (2020) Vol. 49, Iss. 2, pp. 238-246
Open Access | Times Cited: 310
Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US
Donald J. Alcendor
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2442-2442
Open Access | Times Cited: 305
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Argañaraz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 238
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis
Giovanni Corona, Alessandro Pizzocaro, Walter Vena, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 275-296
Open Access | Times Cited: 210
RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells
Taisho Yamada, Seiichi Sato, Yuki Sotoyama, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 820-828
Closed Access | Times Cited: 205
Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients
Kunchok Dorjee, Hyunju Kim, Elizabeth Bonomo, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243191-e0243191
Open Access | Times Cited: 203
Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking
Ayşe Başak Engin, Doruk Engin, Atilla Engin
Environmental Toxicology and Pharmacology (2020) Vol. 78, pp. 103411-103411
Open Access | Times Cited: 183
Interrelations between COVID-19 and other disorders
Amin Gasmi, Massimiliano Peana, Lyudmila Pivina, et al.
Clinical Immunology (2020) Vol. 224, pp. 108651-108651
Open Access | Times Cited: 168
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 9, pp. 1107-1120
Open Access | Times Cited: 165
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study
Y.-Y. Cen, Xi Chen, Yuning Shen, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 9, pp. 1242-1247
Open Access | Times Cited: 158
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 151
Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19
Karla Therese L. Sy, Nel Jason Haw, Jhanna Uy
Infectious Diseases (2020) Vol. 52, Iss. 12, pp. 902-907
Open Access | Times Cited: 150
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States
Michael Fried, Julie M. Crawford, Andrea R. Mospan, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 10, pp. e558-e565
Open Access | Times Cited: 147
Page 1 - Next Page

Scroll to top